Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank44
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P44
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 25.84% |
| 2023 | 36.37% |
| 2022 | 70.79% |
| 2021 | -1469.15% |
| 2020 | -498.02% |
| 2019 | -361.21% |
| 2018 | 133.10% |
| 2017 | 38.45% |
| 2016 | 65.48% |
| 2015 | 0.00% |